Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M482Revenue (TTM) $M426Net Margin (%)-2.4Altman Z-Score1.4
Enterprise Value $M826EPS (TTM) $-0.3Operating Margin %1.9Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-3.4Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio1.8Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %--Current Ratio2.7Lower Leverage y-yN
Price/Free Cash Flow26.5y-y EBITDA Growth Rate %90.8ROA % (ttm)-1.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-3.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M35.7ROIC % (ttm)-8.5Gross Margin Increase y-yY

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIKen Fisher 2015-12-31 Add$17.08 - $20.5
($19.03)
$ 13.51-29%Add 19.06%203,450
AMRIKen Fisher 2015-09-30 Buy 0.01%$17.23 - $22.2
($20.37)
$ 13.51-34%New holding170,876
AMRIJoel Greenblatt 2014-09-30 Sold Out -0.03%$18.7 - $22.89
($20.45)
$ 13.51-34%Sold Out0
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 13.51-20%Reduce -47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 13.51-20%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 13.51-0%New holding48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 13.5110%New holding228,216
AMRIJohn Rogers 2013-03-31 Sold Out -0.04%$5.28 - $10.84
($7.56)
$ 13.5179%Sold Out0
AMRIJohn Rogers 2012-12-31 Reduce-0.01%$3.45 - $5.5
($4.25)
$ 13.51218%Reduce -27.34%372,844
AMRIJohn Rogers 2012-06-30 Buy 0.03%$2.32 - $3.22
($2.81)
$ 13.51381%New holding473,769
AMRIFirst Eagle Investment 2010-12-31 Sold Out $5.05 - $6.93
($5.91)
$ 13.51129%Sold Out0
AMRIFirst Eagle Investment 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 13.5191%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OCONNOR KEVINDirector 2016-05-31Sell5,000$14.41-6.25view
Marth William SPresident and CEO 2016-05-16Buy12,500$12.865.05view
Svokos GeorgeCOO 2016-05-13Buy12,500$12.825.38view
Hagen Steven RSVP Manufacturing & Pharmaceut 2016-05-13Sell2,361$12.775.79view
D AMBRA THOMAS EChairman, Board of Directors 2015-11-09Sell50,000$19.6-31.07view
D AMBRA CONSTANCE M10% Owner 2015-11-09Sell50,000$19.6-31.07view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-17Sell1,000$20.45-33.94view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-07Sell5,000$21.06-35.85view
D AMBRA THOMAS E PHDDirector 2015-06-10Sell20,000$19.77-31.66view
D AMBRA CONSTANCE M10% Owner 2015-06-10Sell20,000$19.77-31.66view

Press Releases about AMRI :

Quarterly/Annual Reports about AMRI:

News about AMRI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 

More From Other Websites
Teewinot Life Sciences Corporation Licenses Biosynthetic Technology to AMRI for the Production and... Jun 22 2016
AMRI Selected as a Dedicated Chemical Biology Consortium Center to Expand Drug Development Jun 14 2016
Albany Molecular Research, Inc. breached its 50 day moving average in a Bearish Manner : AMRI-US :... Jun 13 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 03 2016
Albany Molecular Research, Inc. breached its 50 day moving average in a Bullish Manner : AMRI-US :... Jun 02 2016
AMRI CEO to Present at Jefferies 2016 Healthcare Conference May 23 2016
AMRI CEO to Present at Jefferies 2016 Healthcare Conference May 23 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 20 2016
ETF’s with exposure to Albany Molecular Research, Inc. : May 19, 2016 May 19 2016
ALBANY MOLECULAR RESEARCH INC Financials May 19 2016
Albany Molecular Research, Inc. :AMRI-US: Earnings Analysis: Q1, 2016 By the Numbers May 17 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 11 2016
ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report May 10 2016
Edited Transcript of AMRI earnings conference call or presentation 10-May-16 12:30pm GMT May 10 2016
AMRI Clarifies 2016 Revenue Guidance May 10 2016
Albany Molecular Research Inc Earnings Call scheduled for 8:30 am ET today May 10 2016
Albany Molecular Research posts 1Q loss May 10 2016
Albany Molecular Research posts 1Q loss May 10 2016
AMRI Announces First Quarter 2016 Results May 10 2016
Q1 2016 Albany Molecular Research Inc Earnings Release - Before Market Open May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)